Almetra, Leyden Labs, Kalipso — manufacturing intelligence, antiviral nasal sprays and operational compliance — Daily News June 25, 2026
About this episode
Almetra closes a €16.3M Series A to bring AI directly onto production lines, Leyden Labs raises €40M for its intranasal sprays against influenza and coronaviruses, while Kalipso secures $3.2M to automate European regulatory compliance.
Europe's most interesting startup stories. Every week.
No spam. Unsubscribe anytime.
Startups mentioned
Almetra
Almetra mounts AI cameras above production lines to turn video into operational data - cycle times, output, utilisation - without IT integration, with customers including Bosch, Siemens Energy, ABB and Aumovio.
Leyden Labs
Leyden Labs develops a mucosal protection platform: nasal sprays delivering broadly protective antibodies against influenza and coronaviruses, stopping respiratory viruses before they enter the body.
Kalipso
Kalipso automates regulatory compliance for European financial institutions: it identifies relevant obligations, maps them to existing policies, flags gaps and proposes ready-to-use solutions across frameworks like DORA, MiCAR and the AI Act.